Categories: News

Binaytara Foundation Announces 2023 Career Advancement Award Recipients

The Binaytara Foundation has proudly announced the 2023 Binaytara Career Advancement Awards recipients. The recipients of the 2023 awards attended Binaytara Foundation’s 2023 Annual Summit on Hematologic Cancers, Nashville, TN, and the 2023 Precision Oncology Summit on October 7-8 in San Francisco, CA. These summits feature some of the most prominent leaders in hematology and oncology, providing a platform for groundbreaking discussions and advancements in these fields.

 

The Binaytara Career Advancement Program is a significant initiative aimed at fostering participation, collaboration, and networking among early career professionals and established experts in the field. The 2023 Binaytara Career Advancement recipients, a diverse group of promising physicians and researchers, were selected based on their potential to contribute significantly to the field of hematology and oncology. The foundation’s support underscores its commitment to nurturing the next generation of medical professionals and researchers.

 

The Binaytara Foundation, through such initiatives, continues to play a pivotal role in shaping the future of hematology and oncology. The impact of this program is expected to resonate far beyond the conferences as the recipients bring back valuable insights and connections to their respective institutions and communities.

 

Recipients of the awards include:

 

2023 Annual Summit on Hematologic Cancers Recipients
Alan Cooper – University of Chicago
Dr. Alex Bataller Torralba – MD Anderson Cancer Center
Alexandra Lovell – MD Anderson Cancer Center
Dr. Emmanuel Almanza – MD Anderson Cancer Center
Dr. Fadi Haddad – MD Anderson Cancer Center
Grace Hwang- Pharmacy – MD Anderson Cancer Center
Dr. Greg Roloff – University of Chicago
Dr. Rafael Madero Marroquin – University of Chicago
Dr. Wei Ying JEN – MD Anderson Cancer Center
2023 Precision Oncology Summit Recipients
Georges Gebrael, MD – Huntsman Cancer Institute, University of Utah
Sree Maunika Lanka – Tulane University Deming Department of Medicine
Jason Tasoulas MD, DMD – The University of North Carolina at Chapel Hill
Akshay Prakash – Verdi Cancer Centers
Anam Kamal, MD – Ascension Providence
Arya Mariam Roy, MD – Roswell Park Comprehensive Cancer Center
Marianne Dubard-Gault, MD, MS – The University of Washington/Fred Hutchinson
Dr. Sibapriya Chaudhuri – University of California, San Francisco
Vinay Mathew Thomas, MBBS – University of Utah Health, Huntsman Cancer Institute
Leticia Taniwaki, MD – University of California, San Francisco
Gliceida M Galarza Fortuna – University of Utah, Huntsman Cancer Institute
Yan Leyfman, MD – Icahn School of Medicine at Mount Sinai South Nassau
Gene T. Yoshikawa, MD – Harbor-UCLA Medical Center
Cathleen Park, MD – University of California, Davis
Malak Alharbi, MBBS – Roswell Park Comprehensive Cancer Center
Ebaa Al-Obeidi, MD – University of California, Davis
Jia-Yang Chen, PhD – Acrocyte Therapeutics Inc.
Taylor Pak

Recent Posts

ADRIATIC: durvalumab (D) as consolidation treatment (tx) for patients (pts) with limited-stage small-cell lung cancer (LS-SCLC)

By: Tiantian Zhang1, Yiqun Han2, Lei Deng3 1. Department of Internal Medicine, University of Central…

5 months ago

ASCO24 LAURA Trial Summary

By: Zhiting Tang1, Lei Deng21. Unity Hospital, Rochester Regional Health, Rochester, NY2. University of Washington/Fred…

5 months ago

FDA Approves Tovorafenib for Pediatric Low-Grade Glioma With BRAF Mutation

By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On April 23, 2024, the U.S. Food and Drug…

6 months ago

FDA Approves Tisotumab Vedotin for Recurrent or Metastatic Cervical Cancer

By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On April 29, 2024, the U.S. Food and Drug…

6 months ago

FDA Approves Lutetium Lu 177 Dotatate for SSTR-Positive Gastroenteropancreatic Neuroendocrine Tumors

By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On April 23, 2024, the U.S. Food and Drug…

6 months ago

FDA Approves Alectinib for Adjuvant Treatment in Non-Small Cell Lung Cancer

By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On April 18, 2024, the U.S. Food and Drug…

6 months ago